StreetInsider.com News Articles

Form 8-K SOLESENCE, INC. For: Apr 04

Mon, 07 Apr 2025 16:52:00 -0400

si-local-file:///var/storage/secattach/20250407/24609868.html

Form 8-K SOLESENCE, INC. For: Apr 04

Mon, 07 Apr 2025 16:52:00 -0400

si-local-file:///var/storage/secattach/20250407/24609868.html

Solésence (NANX) Announces Uplisting to Nasdaq

Mon, 07 Apr 2025 16:05:40 -0400

Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company’s shares traded on the OTCQB. Shareholders are not required to take any action as a result of the uplisting.

The Company’s shares will now trade under the ticker symbol “SLSN”. The approval by Nasdaq was

Solésence Announces Uplisting to Nasdaq

Mon, 07 Apr 2025 16:05:00 -0400

Trading set to begin Tuesday, April 8 under new ticker “SLSN”

ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company’s shares traded on the OTCQB. Shareholders are not required to take

Solésence Announces Uplisting to Nasdaq

Mon, 07 Apr 2025 16:05:00 -0400

Trading set to begin Tuesday, April 8 under new ticker “SLSN”

Solésence Announces Uplisting to Nasdaq

Mon, 07 Apr 2025 16:05:00 -0400

Trading set to begin Tuesday, April 8 under new ticker “SLSN”

Solésence Announces Uplisting to Nasdaq

Mon, 07 Apr 2025 16:05:00 -0400

Trading set to begin Tuesday, April 8 under new ticker “SLSN”

Form CERT SOLESENCE, INC.

Mon, 07 Apr 2025 12:11:00 -0400

si-local-file:///var/storage/secattach/20250407/24607901.html

Form CERT SOLESENCE, INC.

Mon, 07 Apr 2025 12:11:00 -0400

si-local-file:///var/storage/secattach/20250407/24607901.html

Form 8-A12B SOLESENCE, INC.

Mon, 07 Apr 2025 08:34:00 -0400

si-local-file:///var/storage/secattach/20250407/24606498.html

Form 8-A12B SOLESENCE, INC.

Mon, 07 Apr 2025 08:34:00 -0400

si-local-file:///var/storage/secattach/20250407/24606498.html

Form 10-K NANOPHASE TECHNOLOGIES For: Dec 31

Mon, 31 Mar 2025 13:58:00 -0400

si-local-file:///var/storage/secattach/20250331/24573596.html

Form 10-K NANOPHASE TECHNOLOGIES For: Dec 31

Mon, 31 Mar 2025 13:58:00 -0400

si-local-file:///var/storage/secattach/20250331/24573596.html

Form 8-K NANOPHASE TECHNOLOGIES For: Mar 26

Wed, 26 Mar 2025 17:25:00 -0400

si-local-file:///var/storage/secattach/20250326/24553730.html

Form 8-K NANOPHASE TECHNOLOGIES For: Mar 26

Wed, 26 Mar 2025 17:25:00 -0400

si-local-file:///var/storage/secattach/20250326/24553730.html

Nanophase Technologies Corporation (NANX) Misses Q4 EPS by 1c

Wed, 26 Mar 2025 17:04:33 -0400

Nanophase Technologies Corporation (OTC: NANX) reported Q4 EPS of ($0.01). Revenue for the quarter came in at $12.57 million.

For earnings history and earnings-related data on Nanophase Technologies Corporation (NANX) click here.

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Wed, 26 Mar 2025 16:24:00 -0400

Fourth quarter revenue increased 58% to a record $12.6 million

Full Year 2024 revenue increased 40% to a record $52.3 million

ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2024.

Recent Highlights and Accomplishments

Company rebranded as Solésence, Inc., marking a new era of innovation, self-expression, and inclusivity in skin health. The move reflects the success of its

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Wed, 26 Mar 2025 16:24:00 -0400

Fourth quarter revenue increased 58% to a record $12.6 million

Full Year 2024 revenue increased 40% to a record $52.3 million

Recent Highlights and Accomplishments

Company rebranded as Solésence, Inc., marking a new era of innovation, self-expression, and inclusivity in skin health. The move reflects the success of its

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Wed, 26 Mar 2025 16:24:00 -0400

Fourth quarter revenue increased 58% to a record $12.6 million

Full Year 2024 revenue increased 40% to a record $52.3 million

Recent Highlights and Accomplishments

Company rebranded as Solésence, Inc., marking a new era of innovation, self-expression, and inclusivity in skin health. The move reflects the success of its

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Wed, 26 Mar 2025 16:24:00 -0400

Fourth quarter revenue increased 58% to a record $12.6 million

Full Year 2024 revenue increased 40% to a record $52.3 million

Recent Highlights and Accomplishments

Company rebranded as Solésence, Inc., marking a new era of innovation, self-expression, and inclusivity in skin health. The move reflects the success of its

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call

Thu, 20 Mar 2025 16:01:00 -0400

ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2024 after the market close on Wednesday, March 26, 2025, and host a conference call and webcast on Thursday, March 27.

Fourth Quarter 2024 Conference Call Details

Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:00 a.m. EDT

Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call

Thu, 20 Mar 2025 16:01:00 -0400

Fourth Quarter 2024 Conference Call Details

Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:00 a.m. EDT

Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call

Thu, 20 Mar 2025 16:01:00 -0400

Fourth Quarter 2024 Conference Call Details

Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:00 a.m. EDT

Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call

Thu, 20 Mar 2025 16:01:00 -0400

Fourth Quarter 2024 Conference Call Details

Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:00 a.m. EDT

Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer

Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win

Thu, 13 Mar 2025 09:00:00 -0400

ROMEOVILLE, Ill., March 13, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that their market-ready product, Au Lait Face Milk SPF 50+ featuring Solésence Kleair™ technology, has been named the winner for best prestige finished formula at the 2025 Cosmetics & Toiletries (C&T) Allē Awards.

The award, which recognizes the company’s achievements across criteria including novelty and practicality, sustainability, safety, stability, and proof of efficacy, marks the company’s third consecutive win at the prestigious Allē Awards. In